117 related articles for article (PubMed ID: 15121754)
21. Suppressor of cytokine signaling gene expression in human pancreatic islets: modulation by cytokines.
Santangelo C; Scipioni A; Marselli L; Marchetti P; Dotta F
Eur J Endocrinol; 2005 Mar; 152(3):485-9. PubMed ID: 15757867
[TBL] [Abstract][Full Text] [Related]
22. The janus kinase inhibitor, Jab/SOCS-1, is an interferon-gamma inducible gene and determines the sensitivity to interferons.
Sakamoto H; Kinjyo I; Yoshimura A
Leuk Lymphoma; 2000 Jun; 38(1-2):49-58. PubMed ID: 10811447
[TBL] [Abstract][Full Text] [Related]
23. Methylation status of suppressor of cytokine signaling-1 gene in hepatocellular carcinoma.
Miyoshi H; Fujie H; Moriya K; Shintani Y; Tsutsumi T; Makuuchi M; Kimura S; Koike K
J Gastroenterol; 2004 Jun; 39(6):563-9. PubMed ID: 15235874
[TBL] [Abstract][Full Text] [Related]
24. Involvement of SOCS-1, the suppressor of cytokine signaling, in the prevention of prolactin-responsive gene expression in decidual cells.
Barkai U; Prigent-Tessier A; Tessier C; Gibori GB; Gibori G
Mol Endocrinol; 2000 Apr; 14(4):554-63. PubMed ID: 10770492
[TBL] [Abstract][Full Text] [Related]
25. Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer.
Kang XC; Chen ML; Yang F; Gao BQ; Yang QH; Zheng WW; Hao S
Biomed Pharmacother; 2016 May; 80():23-29. PubMed ID: 27133036
[TBL] [Abstract][Full Text] [Related]
26. Suppressor of cytokine signalling-1 gene silencing in acute myeloid leukaemia and human haematopoietic cell lines.
Watanabe D; Ezoe S; Fujimoto M; Kimura A; Saito Y; Nagai H; Tachibana I; Matsumura I; Tanaka T; Kanegane H; Miyawaki T; Emi M; Kanakura Y; Kawase I; Naka T; Kishimoto T
Br J Haematol; 2004 Sep; 126(5):726-35. PubMed ID: 15327527
[TBL] [Abstract][Full Text] [Related]
27. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
28. Abundant hypermethylation of SOCS-1 in clinically silent pituitary adenomas.
Buslei R; Kreutzer J; Hofmann B; Schmidt V; Siebzehnrübl F; Hahnen E; Eyupoglu IY; Fahlbusch R; Blümcke I
Acta Neuropathol; 2006 Mar; 111(3):264-71. PubMed ID: 16421738
[TBL] [Abstract][Full Text] [Related]
29. Aberrant promoter methylation and loss of suppressor of cytokine signalling-1 gene expression in the development of uterine cervical carcinogenesis.
Sobti RC; Singh N; Hussain S; Suri V; Nijhawan R; Bharti AC; Bharadwaj M; Das BC
Cell Oncol (Dordr); 2011 Dec; 34(6):533-43. PubMed ID: 21935712
[TBL] [Abstract][Full Text] [Related]
30. [Effects of DNMT1 Gene Silencing on Methylation of SOCS-1 Gene in Myeloma Cells].
Wang Z; Niu XQ; Zhou WW; Lu QY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):713-7. PubMed ID: 26117023
[TBL] [Abstract][Full Text] [Related]
31. SOCS proteins: negative regulators of cytokine signaling.
Krebs DL; Hilton DJ
Stem Cells; 2001; 19(5):378-87. PubMed ID: 11553846
[TBL] [Abstract][Full Text] [Related]
32. Tissue-specific induction of SOCS gene expression by PRL.
Tam SP; Lau P; Djiane J; Hilton DJ; Waters MJ
Endocrinology; 2001 Nov; 142(11):5015-26. PubMed ID: 11606470
[TBL] [Abstract][Full Text] [Related]
33. Hypermethylation of the suppressor of cytokine signalling-1 (SOCS-1) in myelodysplastic syndrome.
Brakensiek K; Länger F; Schlegelberger B; Kreipe H; Lehmann U
Br J Haematol; 2005 Jul; 130(2):209-17. PubMed ID: 16029449
[TBL] [Abstract][Full Text] [Related]
34. Thyrotropin induces SOCS-1 (suppressor of cytokine signaling-1) and SOCS-3 in FRTL-5 thyroid cells.
Park ES; Kim H; Suh JM; Park SJ; Kwon OY; Kim YK; Ro HK; Cho BY; Chung J; Shong M
Mol Endocrinol; 2000 Mar; 14(3):440-8. PubMed ID: 10707961
[TBL] [Abstract][Full Text] [Related]
35. Suppressors of cytokine signalling (SOCS): putative modulators of cytokine bioactivity in health and disease.
Diamond P; Doran P; Brady HR; McGinty A
J Nephrol; 2000; 13(1):9-14. PubMed ID: 10720209
[TBL] [Abstract][Full Text] [Related]
36. [The Role of SOCS in the Development of Tumors].
Liu C; Liu H; Chen J
Zhongguo Fei Ai Za Zhi; 2016 Sep; 19(9):620-5. PubMed ID: 27666555
[TBL] [Abstract][Full Text] [Related]
37. Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction.
Losman JA; Chen XP; Hilton D; Rothman P
J Immunol; 1999 Apr; 162(7):3770-4. PubMed ID: 10201892
[TBL] [Abstract][Full Text] [Related]
38. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms.
Ueki K; Kondo T; Kahn CR
Mol Cell Biol; 2004 Jun; 24(12):5434-46. PubMed ID: 15169905
[TBL] [Abstract][Full Text] [Related]
39. Mycobacterium bovis bacillus Calmette-Guérin infection promotes SOCS induction and inhibits IFN-gamma-stimulated JAK/STAT signaling in J774 macrophages.
Imai K; Kurita-Ochiai T; Ochiai K
FEMS Immunol Med Microbiol; 2003 Nov; 39(2):173-80. PubMed ID: 14625101
[TBL] [Abstract][Full Text] [Related]
40. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction.
Nicholson SE; Willson TA; Farley A; Starr R; Zhang JG; Baca M; Alexander WS; Metcalf D; Hilton DJ; Nicola NA
EMBO J; 1999 Jan; 18(2):375-85. PubMed ID: 9889194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
